Comprehensive National Strategy for HPV Prevention and Treatment in Iran

Document Type : Viewpoint

Authors

1 Department of Oral and Maxillofacial Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran

2 Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran

3 Independent researcher, Tehran, Iran

4 Noosha Darman Ahoora Co. Cell Therapy and Regenerative Medicine, Tehran, Iran

5 School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Keywords


 Introduction

 

Human papillomavirus (HPV), a non-enveloped double-stranded DNA virus from the Papillomaviridae family, is a leading cause of preventable cancers worldwide, responsible for 5% of global malignancies, including cervical, anogenital, and oropharyngeal cancers1,2. In Iran, HPV prevalence is alarmingly high at 38.68%, contributing to approximately 44,600 cancer cases annually3,4. ...(Read more...)


Articles in Press, Accepted Manuscript
Available Online from 03 August 2025
  • Received Date: 06 February 2025
  • Revised Date: 13 May 2025
  • Accepted Date: 02 August 2025
  • First Published Date: 03 August 2025